FIELD: medicine, pharmacy, peptides.
SUBSTANCE: invention relates to new peptides comprising amino acid sequence consisting of 9-55 amino acid residues involving the sequence FTLASAETT (SEQ ID NO:1), pharmaceutical composition used for treatment of autoimmune diseases containing one or more indicated peptides, and pharmaceutically acceptable carrier.
EFFECT: valuable medicinal properties of peptides.
6 cl, 4 tbl, 6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL PEPTIDES THAT CAN BE USED IN ANTIGEN-SPECIFIC IMMUNOSUPPRESSIVE THERAPY | 1997 |
|
RU2199548C2 |
| AUTOANTIGEN AND STRUCTURALLY RELATED PROTEINS FOR USING IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASES | 1997 |
|
RU2189248C2 |
| NOVEL PEPTIDES AS AUTOANTIGEN DERIVATIVES DESIGNATED FOR USE IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASES | 1995 |
|
RU2178797C2 |
| RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
| METHOD OF PREPARING MONOCLONAL ANTIBODY RAISED AGAINST T-CELLS SURFACE ANTIGEN, MONOCLONAL ANTIBODY, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC REAGENT | 1997 |
|
RU2196178C2 |
| METHOD FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERE | 2011 |
|
RU2635537C2 |
| PEPTIDE | 2014 |
|
RU2667428C2 |
| NANOPARTICLE COMPOSITIONS FOR LONG-TERM THERAPY | 2016 |
|
RU2773380C2 |
| PEPTIDES | 2014 |
|
RU2676149C2 |
| NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USE THEREOF | 2014 |
|
RU2689552C2 |
